Alligator Bioscience AB Stock
Stocks
ATORX
SE0024173637
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
20:00:00 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0311 SEK | +2.64% |
|
-14.33% | -90.77% |
| Market Cap | 19.53M 2.06M 1.77M 1.65M 1.51M 2.84M 197M 2.88M 7.62M 99.15M 7.75M 7.58M 328M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 19.53M 2.06M 1.77M 1.65M 1.51M 2.84M 197M 2.88M 7.62M 99.15M 7.75M 7.58M 328M | EV / Sales 2026 * |
0.49x | EV / Sales 2027 * | 3.31x |
| Free-Float |
83.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alligator Bioscience AB
| 1 day | +2.64% | ||
| 1 week | -14.33% | ||
| Current month | -27.34% | ||
| 1 month | -83.97% | ||
| 3 months | -85.30% | ||
| 6 months | -83.13% | ||
| Current year | -90.77% |
| 1 week | 0.03 |  | 0.04 |
| 1 month | 0.03 | | 0.05 |
| Current year | 0.03 | | 0.49 |
| 1 year | 0.03 | | 5.6 |
| 3 years | 0.03 | | 1,568 |
| 5 years | 0.03 | | 6,150 |
| 10 years | 0.03 | | 40,100 |
| Manager | Title | Age | Since |
|---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 55 | 01/06/2021 |
Johan Gileus
DFI | Director of Finance/CFO | 61 | 12/08/2024 |
Tom Moore
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | - | |
| Director/Board Member | 64 | 01/06/2021 | |
Denise Goode
BRD | Director/Board Member | 68 | 09/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/03/25 | Buy | Chairman | 800,000 | 0.0047% | ||
| 05/03/25 | Buy | Chairman | 77,319 | 0.0005% | ||
| 05/03/25 | Sell | Chairman | 1,658,134 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.64% | -14.33% | -99.30% | -99.99% | 2.06M | |
| +1.09% | +5.26% | +4.52% | +26.24% | 51.61B | |
| -1.07% | +2.82% | +465.96% | +586.75% | 44.89B | |
| +1.47% | +9.79% | +35.92% | +21.40% | 42.77B | |
| +1.44% | +7.77% | +19.38% | +92.75% | 42.58B | |
| -0.93% | -4.33% | +16.18% | +53.76% | 31.82B | |
| +1.32% | +7.30% | +33.89% | +150.10% | 17.33B | |
| -0.60% | +1.93% | - | - | 16.63B | |
| +0.03% | +3.41% | +6.55% | +32.10% | 14.76B | |
| +1.28% | +5.41% | +82.40% | +47.43% | 14.09B | |
| Average | +0.67% | +2.56% | +62.83% | +101.17% | 27.65B | |
| Weighted average by Cap. | +0.49% | +4.72% | +99.57% | +146.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.9M 4.21M 3.61M 3.38M 3.09M 5.8M 403M 5.88M 15.56M 203M 15.82M 15.48M 670M | 5.9M 623K 534K 499K 457K 858K 59.61M 869K 2.3M 29.95M 2.34M 2.29M 99.05M |
| Net income | -36.3M -3.83M -3.28M -3.07M -2.81M -5.28M -367M -5.35M -14.16M -184M -14.39M -14.08M -609M | -69.9M -7.38M -6.32M -5.92M -5.42M -10.16M -706M -10.3M -27.26M -355M -27.72M -27.11M -1.17B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | SEK 0.0311 | +2.64% | 8,465,201 |
| 20/08/26 | SEK 0.0303 | -4.42% | 12,695,350 |
| 19/08/26 | SEK 0.0317 | +5.67% | 25,553,055 |
| 18/08/26 | SEK 0.0300 | -9.37% | 19,277,320 |
| 17/08/26 | SEK 0.0331 | -8.82% | 18,316,217 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATORX Stock
Select your edition
All financial news and data tailored to specific country editions
